中国卫生经济
中國衛生經濟
중국위생경제
CHINESE HEALTH ECONOMICS
2014年
1期
63-65
,共3页
新型农村合作医疗%大病保险%利益主体%博弈分析
新型農村閤作醫療%大病保險%利益主體%博弈分析
신형농촌합작의료%대병보험%이익주체%박혁분석
new rural cooperative medical system%critical illness insurance%stakeholder%gaming analysis
目的:明确新型农村合作医疗大病保险各方利益主体间的博弈关系,为新型农村合作医疗大病保险政策的平稳有序推进提供理论参考。方法:运用博弈论对政府、商业保险机构、定点医疗机构和大病参合农民之间的博弈关系进行系统分析。结果:政府与商业保险机构之间、政府与定点医疗机构之间属于合作博弈,大病参合农民在博弈中倾向于选择合作策略。定点医疗机构与商业保险机构、大病参合农民之间倾向于非合作博弈。结论:商业保险机构与定点医疗机构应该迅速建立密切合作的战略关系。政府在加强对商业保险机构、定点医疗机构大病参合农民监管约束的同时,应尽快建立有效的激励机制。
目的:明確新型農村閤作醫療大病保險各方利益主體間的博弈關繫,為新型農村閤作醫療大病保險政策的平穩有序推進提供理論參攷。方法:運用博弈論對政府、商業保險機構、定點醫療機構和大病參閤農民之間的博弈關繫進行繫統分析。結果:政府與商業保險機構之間、政府與定點醫療機構之間屬于閤作博弈,大病參閤農民在博弈中傾嚮于選擇閤作策略。定點醫療機構與商業保險機構、大病參閤農民之間傾嚮于非閤作博弈。結論:商業保險機構與定點醫療機構應該迅速建立密切閤作的戰略關繫。政府在加彊對商業保險機構、定點醫療機構大病參閤農民鑑管約束的同時,應儘快建立有效的激勵機製。
목적:명학신형농촌합작의료대병보험각방이익주체간적박혁관계,위신형농촌합작의료대병보험정책적평은유서추진제공이론삼고。방법:운용박혁론대정부、상업보험궤구、정점의료궤구화대병삼합농민지간적박혁관계진행계통분석。결과:정부여상업보험궤구지간、정부여정점의료궤구지간속우합작박혁,대병삼합농민재박혁중경향우선택합작책략。정점의료궤구여상업보험궤구、대병삼합농민지간경향우비합작박혁。결론:상업보험궤구여정점의료궤구응해신속건립밀절합작적전략관계。정부재가강대상업보험궤구、정점의료궤구대병삼합농민감관약속적동시,응진쾌건립유효적격려궤제。
Objective: To understand the gambling relations between the stakeholders of catastrophic medical insurance policy under New Rural Cooperative Medical System ( NCMS) , and provide theoretical references for the smooth operation of catastrophic medical insurance policy of NCMS. Methods:Analyzing the game relationships among the four sides:the government, business insurance agencies, designated medical institutions and participating farmers suffering from catastrophic diseases through game theory. Results: The government and business insurance agency, and the government and designated medical institution belong to cooperative games. The farmers participated in catastrophic medical insurance tend to choose cooperative strategy. Non-cooperative games exist in business insurance agency, designated medical institution and participating farmers. Conclusion: Strategic relationship of close cooperation should be established between the business insurance agencies and designated medical institutions. The government should strengthen the regulatory constraints between the business insurance agencies and designated medical institutionsi, at the same time, it needs to establish the incentive mechanism soon.